Evaluate releases 2025 Orphan Drug Report

Three Things We Learned in Our Orphan Drugs Webinar

Our recent orphan drugs webinar provided a wealth of insights into the current state and future of the orphan drug market. It was based on our annual report (which is available here) and if you missed it, I recommend taking the time to watch the on-demand version. Our panel included the report’s author, Melanie Senior […] The post Three Things We Learned in Our Orphan Drugs Webinar appeared first on Evaluate.

Evaluate releases 2025 Orphan Drug Report

LONDON —  Evaluate, a leading provider of market insights for the pharmaceutical industry, has released its 2025 Orphan Drug Report highlighting forecasts for the orphan drug market out to 2030.The 2025 report, based on Evaluate Pharma forecasts, projects that orphan drugs will make up a fifth of the forecasted $1.6 trillion in worldwide prescription drug sales by 2030. The segment will continue to outpace the wider pharmaceutical market for the…